RecruitingNCT07684131

EWALL-PH OBSERVARTORY 2022

AN OBSERVATORY FOR PATIENTS AGED 18 YEARS AND OVER WITH PHILADELPHIA CHROMOSOME POSITIVE (PH+ OR BCR::ABL1+) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AND TREATED WITH THE COMBINATION OF BCR::ABL1 INHIBITORS AND CHEMOTHERAPY AND/OR CORTICOSTEROIDS AND/OR A MONOCLONAL ANTIBODY.

Sponsor

Versailles Hospital

Enrollment

100 participants

Start Date

Jan 15, 2024

Study Type

OBSERVATIONAL

Conditions

Acute Lymphoblastic Leukemia

Summary

An observatory for patients aged 18 years and over with Philadelphia chromosome positive (Ph+ or BCR::ABL1) acute lymphoblastic leukemia (ALL) and treated with the combination of BCR::ABL1 inhibitors and chemotherapy and/or corticosteroids and/or a monoclonal antibody.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with acute lymphoblastic leukemia. The study is currently recruiting participants at 23 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(23)

Groupe hospitalier sud

Amiens, France

CHU Angers

Angers, France

CH de la cote basque

Bayonne, France

CHU Bordeaux

Bordeaux, France

Hopital Militaire Percy

Clamart, France

CHU clermont ferrand

Clermont-Ferrand, France

Centre Hospitalier sud francilien

Corbeil-Essonnes, France

CHU de grenoble

Grenoble, France

CHU Sud Réunion

La Réunion, France

CH Versailles

Le Chesnay, France

CH Le Mans

Le Mans, France

Chu de Lille

Lille, France

Hopital de la conception

Marseille, France

Institut Paoli Calmettes

Marseille, France

CHRU de Nancy

Nancy, France

Centre Antoine Lacassagne

Nice, France

Hopital Cochin

Paris, France

Hopital necker

Paris, France

Hopital St Louis

Paris, France

CH de Lyon

Pierre-Bénite, France

CH St Etienne

Saint-Etienne, France

ICANS

Strasbourg, France

Hopital de Purpan

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07684131

Related Trials

Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)

NCT07634653

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

NCT056212918 locations

A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia

NCT072959511 location

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

NCT062879441 location

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

NCT054425151 location